Post-market validation of serological point-of-care tests for COVID-19

A collection of reports about the post-market validation of serological point-of-care tests for COVID-19.

Collection description

The Doherty Institute has evaluated 27 serology-based point of care tests.

The evaluation is part of a review of these tests by the Therapeutic Goods Administration (TGA).

These findings will inform the need for TGA to undertake any post-market action.

This could include changes to the instructions for use to include more information about the limitations of the tests.

Further information is on the TGA’s website, post-market evaluation of serology-based point of care tests.


We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
General public

Help us improve

If you would like a response please use the enquiries form instead.